Diagnosis & Comorbidities in Cushing’s Disease: Incorporating the New Consensus Summary Into Your Practice
| Overview / Abstract: |
This 30 minute CME program highlights the latest expert consensus on best practices for diagnosing Cushing’s disease and managing the comorbidities commonly observed in persons with this rare disorder. Cushing’s disease is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor. Optimal patient outcomes require an accurate diagnosis, proper selection of individualized treatment, and good management of the disease and its associated comorbidities. The program features two experts, Beverly Biller, MD, Professor of Medicine at Harvard Medical School and Maria Fleseriu, MD, Professor of Medicine and Neurological Surgery at Oregon Health and Science University, who were actively involved in the recently published consensus on the diagnosis and management of Cushing’s disease in Lancet Diabetes Endocrinology. |
|
Expiration |
Sep 30, 2023 |
|
Discipline(s) |
Nurse Practitioner , Physician CME, Physician Assistant CME |
|
Format |
Webinar / Webcast / Video |
|
Credits / Hours |
0.5 hours |
|
Accreditation |
American Academy of CME |
|
Presenters / Authors / Faculty |
Beverly MK Biller, MD, Professor of Medicine, Harvard Medical School; Neuroendocrine Clinical Center, Massachusetts General Hospital Maria Fleseriu, MD, FACE, Professor Medicine and Neurological Surgery, Director Pituitary Center, Oregon Health and Science University |
|
Activity Specialities / Related Topics |
Endocrinology, Neurology, Radiology / Imagery / Nuclear Medicine |
|
Sponsors / Supporters / Grant Providers |
Xeris Pharmaceuticals |
|
Keywords / Search Terms |
CheckRare Cusing's disease, rare disease, adrenocorticotropic hormone (ACTH)-secreting pituitary tumor, tumor, Beverly Biller MD, Maria Fleseriu MD, Cushing's disease guidelines, rare disorder, Free CE CME |
|